An assessment of prognostic immunity markers in breast cancer
2018 · npj Breast Cancer · 45 citations
https://doi.org/10.1038/s41523-018-0088-0
B
Benlong Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
714
Citations
15
h-index
24
i10-index
Benlong Yang is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Implant and Reconstruction & HER2/EGFR in Cancer Research. The author has an h-index of 15, co-authored 55 publications.
Papers by this author
worksBenefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCC
2022 · The Breast · 8 citations
https://doi.org/10.1016/j.breast.2022.03.015
Treatment and survival outcomes in older women with primary breast cancer: A retrospective propensity score-matched analysis
2022 · The Breast · 8 citations
https://doi.org/10.1016/j.breast.2022.09.001
Somatic mutations in a multigene panel and impact on prognosis based on <scp>TP53</scp> status in Chinese <scp>HER2</scp>‐positive patients undergoing neoadjuvant therapy: A single‐institution retrospective cohort
2024 · Cancer Medicine · 2 citations
https://doi.org/10.1002/cam4.6955
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat